Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A: results from the botulinum toxin for the upper limb after stroke (BoTULS) trial.

Shackley P, Shaw L, Price C, van Wijck F, Barnes M, Graham L, Ford GA, Steen N, Rodgers H.

Toxins (Basel). 2012 Dec;4(12):1415-26.

PMID:
23342679
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.

PMID:
20515600
[PubMed - indexed for MEDLINE]
Free Article
3.

Cost-effectiveness of onabotulinumtoxinA for the treatment of wrist and hand disability due to upper-limb post-stroke spasticity in Scotland.

Doan QV, Gillard P, Brashear A, Halperin M, Hayward E, Varon S, Lu ZJ.

Eur J Neurol. 2013 May;20(5):773-80. doi: 10.1111/ene.12062. Epub 2012 Dec 24.

PMID:
23278954
[PubMed - indexed for MEDLINE]
4.

Cost-effectiveness of botulinum toxin type a in the treatment of post-stroke spasticity.

Ward A, Roberts G, Warner J, Gillard S.

J Rehabil Med. 2005 Jul;37(4):252-7.

PMID:
16024483
[PubMed - indexed for MEDLINE]
Free Article
5.

Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Rodgers H, Shaw L, Price C, van Wijck F, Barnes M, Graham L, Ford G, Shackley P, Steen N; BoTULS Investigators.

Trials. 2008 Oct 23;9:59. doi: 10.1186/1745-6215-9-59.

PMID:
18947418
[PubMed]
Free PMC Article
6.

Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.

Baguley IJ, Nott MT, Turner-Stokes L, De Graaff S, Katrak P, McCrory P, de Abadal M, Hughes A.

J Rehabil Med. 2011 Nov;43(11):1032-7. doi: 10.2340/16501977-0885.

PMID:
22031350
[PubMed - indexed for MEDLINE]
Free Article
7.

SBOTE study: extracorporeal shock wave therapy versus electrical stimulation after botulinum toxin type a injection for post-stroke spasticity-a prospective randomized trial.

Santamato A, Notarnicola A, Panza F, Ranieri M, Micello MF, Manganotti P, Moretti B, Fortunato F, Filoni S, Fiore P.

Ultrasound Med Biol. 2013 Feb;39(2):283-91. doi: 10.1016/j.ultrasmedbio.2012.09.019. Epub 2012 Dec 14.

PMID:
23245824
[PubMed - indexed for MEDLINE]
8.

Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity.

Borg J, Ward AB, Wissel J, Kulkarni J, Sakel M, Ertzgaard P, Ã…kerlund P, Reuter I, Herrmann C, Satkunam L, Wein T, Girod I, Wright N; BEST Study Group.

J Rehabil Med. 2011 Jan;43(1):15-22. doi: 10.2340/16501977-0663.

PMID:
21174051
[PubMed - indexed for MEDLINE]
Free Article
9.

[Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].

Luauté J, Landrault E, Jacquin-Courtois S, Mertens P, Rode G, Boisson D.

Ann Readapt Med Phys. 2004 Oct;47(8):555-62. French.

PMID:
15465160
[PubMed - indexed for MEDLINE]
10.

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.

PMID:
16545208
[PubMed - indexed for MEDLINE]
Free Article
11.

Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.

Teasell R, Foley N, Pereira S, Sequeira K, Miller T.

Top Stroke Rehabil. 2012 Mar-Apr;19(2):115-21. doi: 10.1310/tsr1902-115. Review.

PMID:
22436359
[PubMed - indexed for MEDLINE]
12.

Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.

Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS.

Neurorehabil Neural Repair. 2012 Sep;26(7):812-21. doi: 10.1177/1545968311430824. Epub 2012 Feb 27.

PMID:
22371239
[PubMed - indexed for MEDLINE]
13.

Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.

Sun SF, Hsu CW, Sun HP, Hwang CW, Yang CL, Wang JL.

Neurorehabil Neural Repair. 2010 Jan;24(1):34-41. doi: 10.1177/1545968309341060. Epub 2009 Sep 3.

PMID:
19729582
[PubMed - indexed for MEDLINE]
14.

Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke.

Santamato A, Panza F, Ranieri M, Frisardi V, Micello MF, Filoni S, Fortunato F, Intiso D, Basciani M, Logroscino G, Fiore P.

J Neural Transm. 2013 Mar;120(3):469-76. doi: 10.1007/s00702-012-0892-x. Epub 2012 Sep 7.

PMID:
22955957
[PubMed - indexed for MEDLINE]
15.

Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.

Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M; GSK1358820 Spasticity Study Group.

J Neurol. 2010 Aug;257(8):1330-7. doi: 10.1007/s00415-010-5526-3. Epub 2010 Apr 1. Erratum in: J Neurol. 2010 Aug;257(8):1416.

PMID:
20358216
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201.

Fiore P, Santamato A, Ranieri M, Bellomo RG, Saggini R, Panza F, Megna G, Cristella G, Megna M.

Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1 Suppl):57S-62S.

PMID:
22652163
[PubMed - indexed for MEDLINE]
17.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

PMID:
16904047
[PubMed - indexed for MEDLINE]
Free Article
18.

Botulinum toxin type A for upper limb spasticity after stroke.

Shaw L, Rodgers H.

Expert Rev Neurother. 2009 Dec;9(12):1713-25. doi: 10.1586/ern.09.121. Review.

PMID:
19951131
[PubMed - indexed for MEDLINE]
19.

Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.

Lukban MB, Rosales RL, Dressler D.

J Neural Transm. 2009 Mar;116(3):319-31. doi: 10.1007/s00702-008-0175-8. Epub 2009 Jan 14. Review.

PMID:
19142573
[PubMed - indexed for MEDLINE]
20.

Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.

Wu JM, Siddiqui NY, Amundsen CL, Myers ER, Havrilesky LJ, Visco AG.

J Urol. 2009 May;181(5):2181-6. doi: 10.1016/j.juro.2009.01.037. Epub 2009 Mar 17.

PMID:
19296983
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk